Venture Capital · Naarden (Netherlands) · Founded 2006
BioGeneration Ventures is a venture capital firm specializing in seed investments for innovative early-stage life sciences companies in Europe. They often act as lead investors and leverage their extensive industry network to accelerate product development. Their portfolio includes biotech companies developing disruptive solutions for high unmet medical needs.
Series A, Series B
BioTech
Acerta Pharma, NorthSea Therapeutics, Scenic Biotech, Tanai Therapeutics, Artica Therapeutics, Avidicure, Azafaros, Brandaris Therapeutics, Brenig, Catalym, Citryll, Complement Therapeutics, Confo Therapeutics, Dunad, Fibrocor, FundaMental Pharma, Genase Therapeutics, Kivu Bioscience, Mironid, Phlox, Phosphoenix, RhyGaze, River BioMedics, RougeTx, STANT, TargED Biopharmaceuticals, Tessellate Bio, Tiga Tx, VarmX, VectorY, XS Innovations, arGEN-X, BioCeros, Dezima Pharma, Lanthio, Mellon Medical, NewAmsterdam Pharma, NovioGendix, Progentix Orthobiology, Staten Biotechnology, SurgVision, Synaffix